(Q37263375)

19 August 2017

1 reference

title

Novel targets with potential therapeutic applications in osteosarcoma (English)

1 reference

19 August 2017

Chand Khanna

1

1 reference

19 August 2017

1 July 2008

1 reference

19 August 2017

Current Oncology Reports

1 reference

19 August 2017

10

1 reference

19 August 2017

350-358

1 reference

19 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-008-0054-3

19 August 2017

0 references

cites work

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0054-3

Characterizing the tumor response to treatment with combretastatin A4 phosphate

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0054-3

Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group

21 January 2018

1 reference

12 December 2020

Translation of new cancer treatments from pet dogs to humans

1 reference

12 December 2020

On the current management of osteosarcoma. A critical evaluation and a proposal for a modified treatment strategy

1 reference

12 December 2020

Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.

1 reference

12 December 2020

Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

1 reference

12 December 2020

Molecular basis for sunitinib efficacy and future clinical development

1 reference

12 December 2020

Clinical relevance of systemic and local IGF-I.

1 reference

12 December 2020

mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: bi-functional compounds for the treatment of bone tumours

1 reference

12 December 2020

Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus.

1 reference

12 December 2020

Targeting the IGF-1 receptor: from rags to riches

1 reference

12 December 2020

The anabolic effects of GH/IGF system on bone

1 reference

12 December 2020

Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma

1 reference

12 December 2020

The role of mTOR inhibitors for treatment of sarcomas

1 reference

12 December 2020

Delta-like 4/Notch signaling and its therapeutic implications

1 reference

12 December 2020

1 reference

12 December 2020

Effect of miconazole on intracellular Ca2+ levels and proliferation in human osteosarcoma cells

1 reference

12 December 2020

Biology of childhood osteogenic sarcoma and potential targets for therapeutic development: meeting summary.

1 reference

12 December 2020

Treatment of metastatic osteosarcoma at diagnosis: a Pediatric Oncology Group Study

1 reference

12 December 2020

Met, metastasis, motility and more

1 reference

12 December 2020

A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy.

1 reference

12 December 2020

Mesenchymal stem cells: molecular targets for tissue engineering

1 reference

12 December 2020

Osteogenic differentiation of the mesenchymal progenitor cells, Kusa is suppressed by Notch signaling

1 reference

12 December 2020

Zoledronic acid - a multiplicity of anti-cancer action

1 reference

12 December 2020

Multimodality treatment of osteosarcoma: radiation in a high-risk cohort

1 reference

12 December 2020

Initial testing of the VEGFR inhibitor AZD2171 by the pediatric preclinical testing program

1 reference

12 December 2020

Reduction in new metastases in breast cancer with adjuvant clodronate treatment

1 reference

12 December 2020

Identification of cryptic microaberrations in osteosarcoma by high-definition oligonucleotide array comparative genomic hybridization

1 reference

12 December 2020

Cancer immunotherapy: a treatment for the masses

1 reference

12 December 2020

The role of the IGF system in cancer growth and metastasis: overview and recent insights

1 reference

12 December 2020

Is angiogenesis an organizing principle in biology and medicine?

1 reference

12 December 2020

Gene amplifications in osteosarcoma-CGH microarray analysis

1 reference

12 December 2020

Cell surface expression of epidermal growth factor receptor and Her-2 with nuclear expression of Her-4 in primary osteosarcoma

1 reference

12 December 2020

Transforming growth factor-beta and the immune response to malignant disease

1 reference

12 December 2020

Zoledronic acid inhibits osteosarcoma growth in an orthotopic model

1 reference

12 December 2020

The RANK/RANKL/OPG triad in cancer-induced bone diseases

1 reference

12 December 2020

c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

1 reference

12 December 2020

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention

1 reference

12 December 2020

Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks

1 reference

12 December 2020

Chemotherapy resistance in osteosarcoma: current challenges and future directions.

1 reference

12 December 2020

Hsp90 inhibitors deplete key anti-apoptotic proteins in pediatric solid tumor cells and demonstrate synergistic anticancer activity with cisplatin

1 reference

12 December 2020

Targeting the molecular chaperone heat shock protein 90 provides a multifaceted effect on diverse cell signaling pathways of cancer cells

1 reference

12 December 2020

Hematogenous micrometastases in osteosarcoma patients

1 reference

12 December 2020

Drugging the cancer chaperone HSP90: combinatorial therapeutic exploitation of oncogene addiction and tumor stress

1 reference

12 December 2020

The MET receptor tyrosine kinase in invasion and metastasis

1 reference

12 December 2020

Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases

1 reference

12 December 2020

Interaction between osteoblast and osteoclast: impact in bone disease

1 reference

12 December 2020

Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271

1 reference

12 December 2020

Initial testing (stage 1) of a monoclonal antibody (SCH 717454) against the IGF-1 receptor by the pediatric preclinical testing program

1 reference

12 December 2020

Recent studies in novel therapy for metastatic sarcomas

1 reference

12 December 2020

New trends in the treatment of bone metastasis

1 reference

12 December 2020

Discovery of a potent, selective, and orally active human epidermal growth factor receptor-2 sheddase inhibitor for the treatment of cancer

1 reference

12 December 2020

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

1 reference

12 December 2020

Modulation by decitabine of gene expression and growth of osteosarcoma U2OS cells in vitro and in xenografts: identification of apoptotic genes as targets for demethylation

1 reference

12 December 2020

ADAM10 as a target for anti-cancer therapy

1 reference

12 December 2020

Silencing the MET oncogene leads to regression of experimental tumors and metastases

1 reference

12 December 2020

The Hsp90 molecular chaperone: an open and shut case for treatment

1 reference

12 December 2020

Expression of Met/hepatocyte growth factor receptor gene and malignant behavior of musculoskeletal tumors.

1 reference

12 December 2020

Markers of angiogenesis and clinical features in patients with sarcoma

1 reference

12 December 2020

Bone biology and physiology: implications for novel osteoblastic osteosarcoma treatments?

1 reference

12 December 2020

Pathotropic nanoparticles for cancer gene therapy Rexin-G IV: three-year clinical experience

1 reference

12 December 2020

Endothelin receptor antagonists in cancer therapy

1 reference

12 December 2020

Preclinical evaluation of antiangiogenic thrombospondin-1 peptide mimetics, ABT-526 and ABT-510, in companion dogs with naturally occurring cancers

1 reference

12 December 2020

Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma

1 reference

12 December 2020

Metastasis: recent discoveries and novel treatment strategies

1 reference

12 December 2020

Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival

1 reference

12 December 2020

Angiogenesis as a therapeutic target

1 reference

12 December 2020

10.1007/S11912-008-0054-3

Identifiers

DOI

1 reference

19 August 2017

0 references

1 reference

PubMed ID

18778562